Impact of Covid-19 in Congenital Heart Disease

CompletedOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 1, 2020

Study Completion Date

December 30, 2020

Conditions
Congenital Heart DiseaseCovid-19
Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors
collaborator

Pr. Jean-Benoît THAMBO, Bordeaux (président)

UNKNOWN

collaborator

Dr. Céline GRUNENWALD GRONIER, Strasbourg

UNKNOWN

collaborator

Dr. Sébastien HASCOET, Le Plessis-Robinson

UNKNOWN

collaborator

Dr. Adeline BASQUIN, Rennes

UNKNOWN

collaborator

Dr. Nicolas COMBES, Toulouse

UNKNOWN

collaborator

Dr. Xavier IRIART, Bordeaux

UNKNOWN

collaborator

Dr. Daniela LAUX, Paris

UNKNOWN

collaborator

Dr. Magalie LADOUCEUR, Paris

UNKNOWN

collaborator

Pr. BERTRAND LEOBON, Toulouse

UNKNOWN

collaborator

Pr. Caroline OVAERT, Marseille

UNKNOWN

collaborator

Dr. Karine WARIN-FRESSE, Nantes

UNKNOWN

collaborator

Alexis BLANC, Montpellier

UNKNOWN

collaborator

Pr. Roland HENAINE, Lyon

UNKNOWN

collaborator

Hamouda ABASSI, Montpellier

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT04336384 - Impact of Covid-19 in Congenital Heart Disease | Biotech Hunter | Biotech Hunter